Paul Jansen

Device & Drug Device Consultant, Board Member (Haselmeier, Subcuject), Advisory Board Member (Evoleen)

Paul Jansen is a prominent Device & Drug Device Consultant affiliated with Kymanox, a consultancy focused on the life sciences sector. He has extensive experience in drug and biologics device development, particularly in the areas of registration, chemistry, manufacturing, and controls (CMC), as well as quality and business development.1 2 3

Professional Background

Experience: Jansen has over 30 years in the industry, having held significant roles at major pharmaceutical companies such as Sanofi and Eli Lilly. His expertise lies primarily in the development of combination products, which integrate drugs with delivery devices.1 4 5
Kymanox Role: As part of the Kymanox Executive Advisors team, he provides strategic insights into the drug-device interface, helping clients navigate complex decisions related to product development and market entry.1 4 His work emphasizes the importance of early strategic thinking in developing combination products, which can significantly influence product design and market success.1

Education

Jansen obtained his education from the University of Toronto, which laid the foundation for his extensive career in drug development and device consulting.2

Contributions to Industry

Jansen is recognized for his contributions to standards related to drug-device combination products through his involvement with industry organizations. He leverages his broad network and deep understanding of emerging technologies to assist pharmaceutical clients in optimizing their product portfolios.1 4

Overall, Paul Jansen's role as a consultant combines his vast experience in pharmaceutical development with a strategic approach to enhancing drug delivery systems.